trial enrollment

Takeda stops phase 2 post-anesthesia trial over slow enrollment

Stopping the phase 2 danavorexton trial because of slow enrollment marked another twist in the development of the orexin-2 receptor agonist franchise.

Nick Paul Taylor Oct 31, 2024 5:29am

red light stop light street traffic signal

Kezar suspends key lupus study after 4 deaths

Sep 30, 2024 11:23am

Genfit moves to jump-start enrollment in liver failure trial

Sep 20, 2024 9:47am

Historical building and Yale university campus in downtown New Haven CT USA

Amgen, Merck join academic clinical trial diversity partnership

Sep 16, 2024 3:10pm

Close up of male doctor holding clipboard while talking to patients waiting in line at medical clinic

Genentech program doubles pace of diverse patient enrollment

Aug 5, 2024 3:15pm

Allucent selected for new BARDA decentralized trial initiative

Jul 10, 2024 5:00am